This result, along with its ease of use, adds to the growing evidence that tenecteplase should be a first-line thrombolytic agent, trial investigators say.
Two new non-inferiority trials support the continued use of intravenous thrombolysis followed by endovascular thrombectomy for large-vessel occlusion stroke.
A new joint scientific statement encourages a pragmatic, case-by-case approach to acute stroke therapies in these patients, citing limitations in available data.
Pediatric patients with large-vessel occlusion stroke are six times more likely to have significant disability if they do not undergo mechanical thrombectomy, a retrospective study suggests.
Registry data suggest that among clots rich in red blood cells, those with low platelet content are associated with less disability and lower mortality after mechanical thrombectomy.